These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 15359268

  • 1. Intravitreal triamcinolone improves vision in eyes with chronic diabetic macular oedema refractory to laser photocoagulation.
    Negi AK, Vernon SA, Lim CS, Owen-Armstrong K.
    Eye (Lond); 2005 Jul; 19(7):747-51. PubMed ID: 15359268
    [Abstract] [Full Text] [Related]

  • 2. Intravitreal triamcinolone as a primary therapy in diabetic macular oedema.
    Karacorlu M, Ozdemir H, Karacorlu S, Alacali N, Mudun B, Burumcek E.
    Eye (Lond); 2005 Apr; 19(4):382-6. PubMed ID: 15309024
    [Abstract] [Full Text] [Related]

  • 3. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
    Mirshahi A, Shenazandi H, Lashay A, Faghihi H, Alimahmoudi A, Dianat S.
    Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
    [Abstract] [Full Text] [Related]

  • 4. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
    Dusová J, Studnicka J, Rencová E, Korda V, Hejcmanová D.
    Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
    [Abstract] [Full Text] [Related]

  • 5. Intravitreal triamcinolone versus laser photocoagulation for persistent diabetic macular oedema.
    Ockrim ZK, Sivaprasad S, Falk S, Roghani S, Bunce C, Gregor Z, Hykin P.
    Br J Ophthalmol; 2008 Jun; 92(6):795-9. PubMed ID: 18420749
    [Abstract] [Full Text] [Related]

  • 6. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial.
    Massin P, Audren F, Haouchine B, Erginay A, Bergmann JF, Benosman R, Caulin C, Gaudric A.
    Ophthalmology; 2004 Feb; 111(2):218-24; discussion 224-5. PubMed ID: 15019365
    [Abstract] [Full Text] [Related]

  • 7. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial.
    Sutter FK, Simpson JM, Gillies MC.
    Ophthalmology; 2004 Nov; 111(11):2044-9. PubMed ID: 15522370
    [Abstract] [Full Text] [Related]

  • 8. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes.
    Lam DS, Chan CK, Mohamed S, Lai TY, Lee VY, Liu DT, Li KK, Li PS, Shanmugam MP.
    Ophthalmology; 2007 Dec; 114(12):2162-7. PubMed ID: 17459479
    [Abstract] [Full Text] [Related]

  • 9. Improved visual acuity and macular thickness 1 week after intravitreal triamcinolone for diabetic macular oedema.
    Islam MS, Negi A, Vernon SA.
    Eye (Lond); 2005 Dec; 19(12):1325-7. PubMed ID: 15578081
    [Abstract] [Full Text] [Related]

  • 10. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
    Ozdek S, Bahçeci UA, Gürelik G, Hasanreisoğlu B.
    J Diabetes Complications; 2006 Dec; 20(4):246-51. PubMed ID: 16798476
    [Abstract] [Full Text] [Related]

  • 11. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
    Gillies MC, Sutter FK, Simpson JM, Larsson J, Ali H, Zhu M.
    Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501
    [Abstract] [Full Text] [Related]

  • 12. Intravitreal cortisone injection for refractory diffuse diabetic macular edema.
    Er H, Yilmaz H.
    Ophthalmologica; 2005 Sep; 219(6):394-400. PubMed ID: 16286802
    [Abstract] [Full Text] [Related]

  • 13. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
    Avitabile T, Longo A, Reibaldi A.
    Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521
    [Abstract] [Full Text] [Related]

  • 14. Intravitreal triamcinolone acetonide for treatment of persistent macular oedema in branch retinal vein occlusion.
    Ozkiris A, Evereklioglu C, Erkilic K, Dogan H.
    Eye (Lond); 2006 Jan; 20(1):13-7. PubMed ID: 15723039
    [Abstract] [Full Text] [Related]

  • 15. The transient efficacy of a single intravitreal triamcinolone acetonide injection for diabetic macular edema.
    Desatnik H, Habot-Wilner Z, Alhalel A, Moroz I, Glovinsky J, Moisseiev J.
    Isr Med Assoc J; 2006 Jun; 8(6):383-7. PubMed ID: 16833165
    [Abstract] [Full Text] [Related]

  • 16. Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial.
    Audren F, Erginay A, Haouchine B, Benosman R, Conrath J, Bergmann JF, Gaudric A, Massin P.
    Acta Ophthalmol Scand; 2006 Oct; 84(5):624-30. PubMed ID: 16965492
    [Abstract] [Full Text] [Related]

  • 17. Intravitreal triamcinolone for diffuse diabetic macular oedema.
    Gibran SK, Cullinane A, Jungkim S, Cleary PE.
    Eye (Lond); 2006 Jun; 20(6):720-4. PubMed ID: 16021193
    [Abstract] [Full Text] [Related]

  • 18. [Intravitreal injection of crystalline triamcinolone acetonide in the treatment of diffuse diabetic macular oedema].
    Jonas JB, Degenring R.
    Klin Monbl Augenheilkd; 2002 Jun; 219(6):429-32. PubMed ID: 12136438
    [Abstract] [Full Text] [Related]

  • 19. Intravitreal triamcinolone as adjunctive treatment to laser panretinal photocoagulation for concomitant proliferative diabetic retinopathy and clinically significant macular oedema.
    Margolis R, Singh RP, Bhatnagar P, Kaiser PK.
    Acta Ophthalmol; 2008 Feb; 86(1):105-10. PubMed ID: 17608830
    [Abstract] [Full Text] [Related]

  • 20. [Macular oedema and intravitreal triamcinolone injections].
    Gunnlaugsdóttir E, Oehman DO, Gunnarsdóttir SG, Stefánsson E.
    Laeknabladid; 2006 Dec; 92(12):847-57. PubMed ID: 17206015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.